Filtered By:
Cancer: Gastric (Stomach) Cancer
This page shows you your search results in order of date. This is page number 7.
Order by Relevance | Date
Total 20058 results found since Jan 2013.
Correlation of microsatellite status and EBV infection with clinical characteristics of patients with gastric cancer
This study was designed to investigate the correlation of microsatellite status (MS) and Epstein-Barr virus (EBV) infection with the clinical characteristics of gastric cancer (GC) patients. MS was detected by immunohistochemistry. EBV was detected by in situ hybridization. There were 31.3% cases showed mismatch repair-deficient (dMMR)/ microsatellite instability (MSI) and 68.7% cases showed mismatch repair-proficient (pMMR)/ microsatellite stability (MSS). The dMMR/MSI was more common in the elderly, in patients with cardia GC, smaller tumor diameter or non-poorly differentiated carcinoma. The survival in dMMR/MSI patient...
Source: General Physiology and Biophysics - September 13, 2023 Category: Physiology Authors: Pengfei Lu Kadeliya Yushan Gulimilai Yusufu Hiu Wang Rui Mao Source Type: research
Efficacy and safety of totally laparoscopic gastrectomy with uncut Roux-en-Y for gastric cancer: a dual-center retrospective study
Uncut Roux-en-Y (URY) effectively alleviates the prevalent complexities connected with RY, such as Roux-en-Y stasis syndrome (RSS). Nevertheless, for gastric cancer (GC) patients, it is still controversial whe...
Source: World Journal of Surgical Oncology - September 13, 2023 Category: Cancer & Oncology Authors: Yizhen Chen, Yuanyuan Zheng, Song Tan, Yifan Chen, Tao Zheng, Shaolin Liu, Yulong Mi, Shentao Lin, Changshun Yang, Jian Jiang and Weihua Li Tags: Research Source Type: research
Tanshinone I attenuates gastric precancerous lesions by inhibiting epithelial mesenchymal transition through the p38/STAT3 pathway
CONCLUSION: This study showed that Tan-I inhibited the progression of GPLs by reversing the EMT process and reducing inflammation by restraining the p38/STAT3 signaling pathway.PMID:37699302 | DOI:10.1016/j.intimp.2023.110902
Source: International Immunopharmacology - September 12, 2023 Category: Allergy & Immunology Authors: Dan Liang Shiyun Tang Lu Liu Maoyuan Zhao Xiao Ma Yanling Zhao Caifei Shen Qingsong Liu Jianyuan Tang Jinhao Zeng Nianzhi Chen Source Type: research
Presentation of Gastrointestinal Stromal Tumor, Pancreatic Adenocarcinoma, and Gastric Adenocarcinoma in a Woman With No Identifiable Genetic Abnormalities
This report details the first known case of co-occurrence of gastrointestinal stromal tumor (GIST), pancreatic adenocarcinoma, and gastric adenocarcinoma in an individual with no identifiable genetic abnormalities. The patient is a 57-year-old female who presented with abdominal pain. CT scan demonstrated a pancreatic mass, and endoscopic ultrasound demonstrated an additional gastric mass. Biopsy of both masses demonstrated adenocarcinoma; however, the masses were found to have different origins. The patient underwent neoadjuvant chemotherapy with excellent response. She then underwent surgical intervention, which demonstr...
Source: The American Surgeon - September 12, 2023 Category: Surgery Authors: Catherine Read Marybeth Hughes Omar Itani Source Type: research
Activation of the DNA damage response pathway in the infected gastric tissue with Helicobacter pylori: a case-control study
CONCLUSIONS: Our results provide new data that may support the potential involvement of H. pylori infection in the activation of genes involved in DNA damage response, mainly through a non-homologous end-joining DNA repair system that might be linked to mutagenesis in the pre-cancerous gastric tissue.PMID:37699095 | DOI:10.3855/jidc.17655
Source: Cancer Control - September 12, 2023 Category: Cancer & Oncology Authors: Amiratabak Rajaei Armin Ghameshlou Reza Shirkoohi Abbas Shakoori Farahani Seyedeh Zohre Mirbagheri Ronak Bakhtiari Melika Sadat Haeri Ali Rashidi-Nezhad Masoud Alebouyeh Source Type: research
Presentation of Gastrointestinal Stromal Tumor, Pancreatic Adenocarcinoma, and Gastric Adenocarcinoma in a Woman With No Identifiable Genetic Abnormalities
This report details the first known case of co-occurrence of gastrointestinal stromal tumor (GIST), pancreatic adenocarcinoma, and gastric adenocarcinoma in an individual with no identifiable genetic abnormalities. The patient is a 57-year-old female who presented with abdominal pain. CT scan demonstrated a pancreatic mass, and endoscopic ultrasound demonstrated an additional gastric mass. Biopsy of both masses demonstrated adenocarcinoma; however, the masses were found to have different origins. The patient underwent neoadjuvant chemotherapy with excellent response. She then underwent surgical intervention, which demonstr...
Source: The American Surgeon - September 12, 2023 Category: Surgery Authors: Catherine Read Marybeth Hughes Omar Itani Source Type: research
Quercetin action on health and female reproduction in mammals
Crit Rev Food Sci Nutr. 2023 Sep 12:1-15. doi: 10.1080/10408398.2023.2256001. Online ahead of print.ABSTRACTThis paper reviews the current information concerning availability, metabolism of quercetin, its effects on physiological processes and illnesses with focus on the effects, mechanisms of action and areas of possible application of quercetin in control of female reproductive processes, prevention and treatment of their disorders in mammals.The available information demonstrated the ability of quercetin and its analogues to inhibit proliferation and to promote apoptosis, to activate regenerative processes, to treat imm...
Source: Cancer Control - September 12, 2023 Category: Cancer & Oncology Authors: Alexander V Sirotkin Source Type: research
Clinical significance of expression level of ZNF471 in gastric cancer
CONCLUSION: ZNF471 functions as a tumor suppressor during the pathogenesis of GC. Thus, it is a promising biomarker for diagnosis and therapy of GC.PMID:37693683 | PMC:PMC10492033
Source: International Journal of Clinical and Experimental Pathology - September 11, 2023 Category: Pathology Authors: Siyuan Li Diyang Chen Huamin Zhang Yong Yang Jianguo Huai Linna Huang Kai Fan Tongyuan Lin Baijing Ding Source Type: research
The disappearance of gastric metastasis and liver metastasis in non-small cell lung adenocarcinoma is due to osimertinib
CONCLUSIONS: This is the first report to our knowledge of a patient who presented with gastric and hepatic metastases from lung cancer and achieved complete remission with osimertinib and local radiotherapy, with good quality of life, which also provides a basis for future clinical work and is of great significance.PMID:37695388 | DOI:10.1007/s00432-023-05386-7
Source: Clinical Lung Cancer - September 11, 2023 Category: Cancer & Oncology Authors: Yun Wang Chao Yan Chuantao Zhang Enhao Yu Kai Wang Xiangyong Liu Jie Yu Chunyang Zhou Aijie Yang Source Type: research
Study of LncRNA BANCR Expression in Tumor Tissues and Adjacent Normal Tissues in Gastric Cancer Patients
CONCLUSIONS: The observed upregulation of BANCR in GC tissues implies its potential involvement as an oncogenic lncRNA in GC patients. Furthermore, BANCR may serve as a promising biomarker for identification and treatment of GC.PMID:37694252 | PMC:PMC10492603 | DOI:10.4103/abr.abr_260_22
Source: Biomed Res - September 11, 2023 Category: Research Authors: Raha Nikanfar Rozhin Dabbaghi Ali Rajabi Shahriar Hashemzadeh Behzad Baradaran Shahram Teimourian Reza Safaralizadeh Source Type: research
Neoadjuvant PD-1 inhibitor plus apatinib and chemotherapy versus apatinib plus chemotherapy versus chemotherapy alone in patients with locally advanced gastric cancer
This study aimed to evaluate this combination as a neoadjuvant therapy in locally advanced gastric cancer (LAGC). In this retrospective study, data from 179 LAGC patients who underwent neoadjuvant therapy with a PD-1 inhibitor plus apatinib and chemotherapy (PAC group, n=56), apatinib and chemotherapy (AC group, n=50), or chemotherapy alone (C group, n=73) were analyzed. The PAC group displayed a numerically higher radiologic objective response rate than the AC group (73.2% vs. 60.0%, P=0.149) and significantly higher than the C group (73.2% vs. 35.6%, P<0.001). Tumor resection rates between the PAC and AC groups were n...
Source: Cell Research - September 11, 2023 Category: Cytology Authors: Hui Xiong Yun Li Source Type: research
